# EDGAR Filing Document

**Accession Number:** 0001866547
**File Stem:** 0001493152-23-007907
**Filing Date:** 2023-3
**Character Count:** 9254
**Document Hash:** a8364a93f552d0ecddeb0c1553827705
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-007907.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001493152-23-007907

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230316

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aetherium Acquisition Corp
- **CENTRAL INDEX KEY:** 0001866547
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41189
- **FILM NUMBER:** 23739064

**BUSINESS ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831
- **BUSINESS PHONE:** (650) 450-6836

**MAIL ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**March 16, 2023**

Date of Report (Date of earliest event reported)

**<u>Aetherium Acquisition Corp.</u>**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41189** | **86-3449713** |
| (State or other jurisdiction of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **79B Pemberwick Rd.**<br> **Greenwich, CT** | **06831** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(650) 450-6836**

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act

☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant | GMFIU | The Nasdaq Stock Market LLC |
| Class A Common Stock, par value $0.0001 per share | GMFI | The Nasdaq Stock Market LLC |
| Warrants | GMFIW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01 Other Events**

As previously disclosed, Aetherium Acquisition Corp. ("**<u>Aetherium</u>**" or the "**<u>Company</u>**") has called a special meeting (the "**<u>Meeting</u>**") for stockholders to consider and vote on (1) a proposal to amend Aetherium's amended and restated certificate of incorporation, to extend the date by which Aetherium must consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period (each an "**<u>Extension</u>**"), from April 3, 2023 to April 3, 2024 (we refer to this proposal as the "**<u>Charter Amendment Proposal</u>**"); and (2) a proposal to amend Aetherium's investment management trust agreement, dated as of December 29, 2021, by and between Aetherium and Continental Stock Transfer & Trust Company, allowing Aetherium to extend the date by which Aetherium must consummate a business combination up to twelve (12) times, each such Extension for an additional one (1) month period, until April 3, 2024, by depositing into the Trust Account lesser of (A) $0.055 per non-redeeming share of Aetherium's Class A common stock, $0.0001 par value, and (B) $150,000 for each one-month Extension (we refer to this proposal as the "**<u>Trust Amendment Proposal</u>**" and together with the Charter Amendment Proposal, the "**<u>Extension Proposals</u>**").

As described in the proxy statement dated March 6, 2023 mailed in connection with the Meeting (the "**<u>Proxy Statement</u>**"), pursuant to the Inflation Reduction Act of 2022 (the "**<u>IR Act</u>**"), commencing in 2023, a 1% U.S. federal excise tax is imposed on certain repurchases (including redemptions) of stock by "covered corporations" occurring on or after January 1, 2023. As a result, any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Notwithstanding the foregoing, except for franchise taxes and income taxes, the proceeds placed in the trust account established for the benefit of the Company's public stockholders and maintained by Continental Stock Transfer & Trust Company, acting as trustee, and the interest earned thereon, shall not be used to pay for possible excise tax or any other fees or taxes that may be levied on us pursuant to any current, pending or future rules or laws, including without limitation any excise tax due under the IR Act on any redemptions or stock buybacks by us.

**Forward-Looking Statements**

This Current Report on Form 8-K (the "**<u>Report</u>**") includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, the risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission ("**<u>SEC</u>**"). Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

**Participants in the Solicitation**

The Company and its directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the securityholders of the Company in favor of the approval of the Extension Proposals. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and officers in the Proxy Statement, which may be obtained free of charge from the sources indicated below.

**No Offer or Solicitation**

This Report shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

**Additional Information and Where to Find It**

The Company urges investors, stockholders and other interested persons to read the Proxy Statement as well as other documents filed by the Company with the SEC, because these documents will contain important information about the Company and the Extension Proposals. Stockholders may obtain copies of the Proxy Statement, without charge, at the SEC's website at *www.sec.gov* or by directing a request to the Company's proxy solicitor, Advantage Proxy, Inc., P.O. Box 13581, Des Moines, WA 98198, Attn: Karen Smith, Toll Free Telephone: (877) 870-8565, Main Telephone: (206) 870-8565, E-mail: ksmith@advantageproxy.com.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Dated: March 16, 2023 | Dated: March 16, 2023 |
| AETHERIUM ACQUISITION CORP. | AETHERIUM ACQUISITION CORP. |
| By: | */s/ Jonathan Chan* |
| Name: | Jonathan Chan |
| Title: | Chief Executive Officer and Chairman |

---